Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.640
+0.610 (20.13%)
Aug 14, 2025, 3:37 PM - Market open
Biomerica Market Cap
Biomerica has a market cap or net worth of $9.27 million as of August 14, 2025. Its market cap has increased by 65.47% in one year.
Market Cap
9.27M
Enterprise Value
6.78M
1-Year Change
65.47%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since August 29, 2016, Biomerica's market cap has decreased from $24.30M to $9.27M, a decrease of -61.87%. That is a compound annual growth rate of -10.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 7.70M | 54.00% |
| Dec 31, 2024 | 5.00M | -76.19% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | -22.63% |
| Aug 29, 2016 | 24.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 606.38B |
| Johnson & Johnson | 420.59B |
| AbbVie | 361.54B |
| UnitedHealth Group | 244.53B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.15B |